Debates & Insight Sponsored Digital health: how can technology be used to engage hard-to... Helping someone live with a condition as complex as MS can be fraught with challenges.
Views & Analysis Behavioural science + medical education: a transformative co... ‘We need to walk in the shoes of HCPs and patients if we are to design programmes that improve health outcomes.’
News Lexicon's type 1 diabetes drug voted down by FDA adcomm It has been five years since Lexicon Pharma's type 1 diabetes therapy, Zynquista, was rejected by the FDA, and it may struggle to have a better outcome at its second attempt.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.